← Companies
CATALYST PHARMACEUTICALS, INC.
Data as of Sep 17, 2026
Reported federal lobbying
$270K
9 filings · latest Jul 20, 2026
Federal contracts since 2024
$76K
7 awards · latest Jul 18, 2026
Lobbying
$270,000 in reported federal lobbying spend across 9 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues$270K9 filings
Latest filings, Sep 2025 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 20, 2026 | JEFFREY J. KIMBELL & ASSOCIATES, INC. for CATALYST PHARMACEUTICALS Health Issues General FDA issues related to orphan drugs | $30,000 |
| Apr 20, 2026 | JEFFREY J. KIMBELL & ASSOCIATES, INC. for CATALYST PHARMACEUTICALS Health Issues General FDA issues related to orphan drugs | $30,000 |
| Mar 9, 2026 | JEFFREY J. KIMBELL & ASSOCIATES, INC. for CATALYST PHARMACEUTICALS Health Issues General FDA issues related to orphan drugs | $30,000 |
| Jan 20, 2026 | JEFFREY J. KIMBELL & ASSOCIATES, INC. for CATALYST PHARMACEUTICALS Health Issues General FDA issues related to orphan drugs | $30,000 |
| Oct 20, 2025 | JEFFREY J. KIMBELL AND ASSOCIATES for CATALYST PHARMACEUTICALS Health Issues General FDA issues related to orphan drugs | $30,000 |
| Sep 25, 2025 | JEFFREY J. KIMBELL & ASSOCIATES, INC. for CATALYST PHARMACEUTICALS Health Issues General FDA issues related to orphan drugs | $30,000 |